| NEWSLETTER
- NOVEMBER 2007 |
|
 |
| |
|
Open Positions for Life Sciences Executives
Ashton Tweed is recruiting for several exciting life sciences opportunities.
Below is a selection of the open positions. Qualified candidates for all positions are invited to submit their
resumes to info@ashtontweed.com.
Title: U.S. Clinical Project Manager
Company: Australia-based drug company entering the United States market with offices
located in the suburban Philadelphia region
Description: Reports to the U.S. Medical Director and manages all phases and
responsibilities for national and international clinical trials and project teams to ensure
patient safety and data integrity.
Title: Strategic Market Research
Company: Global drug delivery company headquartered in suburban Philadelphia
Description: Reports to the Vice President, Strategic Marketing and the role requires
3-5 years experience in pharma/biotech/medical device market research, analytics and forecasting.
Title: Strategic Marketing (4 senior positions)
Company: International specialty pharmaceutical company, headquartered in Montreal, Canada.
The company is an emerging leader in drug delivery and is expanding its U.S. commercial operations
in the Greater Philadelphia region.
Description: Positions cover the EU, Latin America/Australasia, North America and New Product
Development for CNS product lines. The roles require 10+ years of pharmaceutical/biotechnology
industry experience in worldwide strategic marketing with an emphasis on markets outside the U.S.
and report directly to the president.
Title: VP Medical and VP Regulatory Affairs
Company: The company develops pharmaceutical and biopharmaceutical products
using proprietary drug formulation technologies.
Description: The newly established U.S. commercial business unit will promote niche
products in targeted therapeutic areas.
Back to top |
|
|
The ASHTON TWEED DIFFERENCE
Immediate access to highly
skilled talent
through the first Executive Talent Bank dedicated to the Life
Sciences Industry.
Diverse range of options for
human capital and commercialization management needs
- interim talent, retained executive search and commercialization
consulting.
Significant Life Sciences
Industry experience
from partners with diverse backgrounds in the Life Sciences
Industry and who understand the specific challenges Life Sciences
clients face.
Personal attention where
each client and candidate receives personal attention by a
member of our Leadership Team.
|
|
 |
| UPCOMING EVENTS
Overcoming Barriers Faced When Bringing a Bio-Nanotechnology Product to Market
December 20, 2007
University of the Sciences in Philadelphia
This panel sponsored by Pennsylvania Bio and Ben Franklin Technology Partners will address the general
business climate for bio-nanotechnology startups and mature companies, including factors shaping intellectual
property, potential litigation issues, and how to deal with the new regulatory environment.
For more information, please visit the Pennsylvania
BIO web site.
|
|
Ashton Tweed Serves as Gold Sponsor for Schoemaker Golf Classic
On Monday, October 22, Ashton Tweed partners Jim Rudman, James Laird and Jordan Warshafsky participated in the 2nd Annual Hubert J.P. Schoemaker Golf Classic Gala Dinner and Auction. The tournament was sponsored by GlaxoSmithKline in memory of Philadelphia biotech leader and former CEO of Centocor, Hubert Schoemaker. The event included golf, a dinner and a silent and live auction that raised over $300,000 for Melmark.
Melmark, a comprehensive multi-service agency for children and adults with developmental disabilities in Pennsylvania and Massachusetts, is a beneficiary long supported by Hubert Schoemaker as his daughter has resided at Melmark for twenty-five years. Melmark's programs promote independence, self-awareness, and confidence, while offering participants opportunities to make friends and develop personal interests.
Ashton Tweed Partners Jordan Warshafsky and Jim Rudman with Ron Schmid at the Schoemaker Classic Gala
Ashton Tweed is pleased to have served as a Gold Sponsor for this year's event. The golf tournament experienced such enthusiastic turn-out that it added a third course, Stonewall in Elverson, PA, this year in addition to last year's returning courses Waynesborough Country Club in Paoli, PA and the White Manor Country Club in Malvern, PA. This year's event featured a total of 210 golfers and 300 dinner attendees.
"Ashton Tweed is thrilled to support the 2nd Annual Hubert Schoemaker Classic. It is heartening to see our local community come together to honor Hubert's legacy and to support the great work of Melmark. We look forward to next year's successful tournament," said Jim Rudman, CEO, Ashton Tweed.
To learn more about Melmark and the event, please visit the Schoemaker Classic page, www.schoemakerclassic.com.
Back to top |
|
| UPCOMING
EVENTS Drug Delivery Partnerships
January 21-23, 2008
Manchester Grand Hyatt
San Diego, CA
Drug Delivery Partnerships offers participants workshops on the drug delivery landscape, as well as exhibits, company case studies and networking opportunities.
For more information, please visit the event web site. |
|
|
|
Biotech 2007 Highlights Mid-Atlantic Life Sciences Community
On October 8-9, Ashton Tweed Partners Jordan Warshafsky and James Laird attended the Biotech 2007 conference in Philadelphia. Biotech 2007's goal is to advance the growth and development of the bioscience industry in the Mid-Atlantic region. The conference, with an attendance of over 900 from 330 organizations, facilitated networking opportunities among emerging companies, researchers, large pharmaceutical companies, and support organizations.
The conference, held at the Loews Philadelphia Hotel, included 21 panel discussions, a business development forum, innovation corridor, career fair, and exhibit hall. Biotech 2007 was a great opportunity for Jordan and Jim to meet with senior management of new Pennsylvania Bio member companies. Many of the new contacts we met at the event expressed enthusiastic interest in Ashton Tweed's interim executive program. Interim executives allow companies to immediately address urgent business issues within a clearly defined time frame and turn the company's fixed talent cost into a variable expense. Employing interim executives allows companies to bridge any downtime and gives them access to experts with backgrounds throughout the entire discovery to commercialization continuum.
For more information on the conference, please visit www.biotech2007.org.
Back to top
|
|
|
|
|
BioPortUSA Update
October and November have been extremely busy months for BioPortUSA. We attended the AusBiotech 2007 conference in Brisbane, Australia (October 22 – 24th) and BIO-Europe conference in Hamburg, Germany (Nov 12 – 14th).
Representing BioPortUSA in Australia, Chris Blaxland participated in over 15 partnering meetings at the Ausbiotech conference and held several more meetings in Sydney with companies that were not planning to attend AusBiotech. The meetings were a success and garnered BioPortUSA a new client, a specialist pharmaceutical company established to research, develop and bring to market human therapeutic products to treat chronic respiratory and autoimmune diseases.
BioPortUSA CEO James Laird (2nd from r.) with attendees at BIO Europe
Both James Laird and Chris Blaxland attended BIO Europe in Hamburg. The conference featured over 2000 registered delegates from 1150 participating companies. Jim and Chris met with representatives of 50 companies who expressed interest in entering the U.S. market. BioPortUSA kicked off the conference by co-sponsoring a dinner event with Select Greater Philadelphia and The Science Center. Guests at the dinner included Warren Cooper, CEO of Prism Pharmaceuticals; Ezra Felker, VP Business Development, NuPathe Inc., and several international Life Sciences executives whose firms were considering their entry strategy to the U.S. marketplace.
For more information on BioPortUSA, please visit www.BioPortUSA.com.
Back to top
|
|
|
|
